CARDIOVASCULAR AND CORONARY RISK ESTIMATION IN HYPERTENSION MANAGEMENT

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Heart

• Publication date

  2002-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/heart.88.3.306PMID 12181232PMCID PMC1767334
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack.

  2003cited by this paper
• What benefit do patients expect from adding second and third antihypertensive drugs?

  2002cited by this paper
• Is coronary risk an accurate surrogate for cardiovascular risk for treatment decisions in mild hypertension? A population validation

  2001cited by this paper
• What is the optimal age for starting lipid lowering treatment? A mathematical model

  2000cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.

  2000cited by this paper
• Coronary and cardiovascular risk estimation for primary prevention:validation of a new Sheffield table in the 1995 Scottish health survey population

  2000cited by this paper
• Optimal age for starting lipid lowering treatment

  2000cited by this paper
• Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study.

  2000cited by this paper
• Optimal age for starting lipid lowering treatment. Adjusted date do not justify a lower optimal age.

  2000cited by this paper
• Guidelines for the management of hypertension.

  2000cited by this paper
• Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)

  2000cited by this paper
• A simple computer program for guiding management of cardiovascular risk factors and prescribing

  1999cited by this paper
• Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men

  1999cited by this paper
• Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension.

  1999cited by this paper
• Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.

  1999cited by this paper
• British Hypertension Society guidelines for hypertension management 1999: summary

  1999cited by this paper
• Guidelines for management of hypertension: report of the third working party of the British Hypertension Society

  1999cited by this paper
• The rationale for differing national recommendations for the treatment of hypertension.

  1998cited by this paper
• Joint British recommendations on prevention of coronary heart disease in clinical practice

  1998cited by this paper
• Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention.

  1998cited by this paper
• Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention.

  1998cited by this paper
• The rationing debate: Rationing health care by age: The case for

  1997cited by this paper
• The hypertension detection and follow-up program: 17 years on.

  1997cited by this paper
• Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension *

  1997cited by this paper
• 4.3 The impact of ambulatory blood pressure on estimation of cardiovascular risk in mild hypertension

  1997cited by this paper
• Interpretation of prospective trials in hypertension: do treatment guidelines accurately reflect current evidence?

  1996cited by this paper
• Guidelines for antihypertensive therapy: problems with a strategy based on absolute cardiovascular risk.

  1996cited by this paper
• Guidelines for antihypertensive therapy: problems with a strategy based on absolute cardiovascular risk.

  1996cited by this paper
• An evidence based approach to individualising treatment

  1995cited by this paper
• Does drug treatment improve survival? Reconciling the trials in mild‐to-moderate hypertension

  1995cited by this paper
• Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work?

  1995cited by this paper
• Risks and benefits of treating mild hypertension: a misleading meta-analysis?

  1995cited by this paper
• The number needed to treat: a clinically useful measure of treatment effect

  1995cited by this paper
• Treatment of Mild Hypertension Study: Final Results

  1993cited by this paper
• Cardiovascular disease risk profiles.

  1991cited by this paper
• Labelling of hypertensives: a review of the data.

  1990cited by this paper
• Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

  1990cited by this paper
• Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

  1990cited by this paper
• Mild hypertension: treat patients, not populations.

  1985cited by this paper
• On the elicitation of preferences for alternative therapies.

  1982cited by this paper
• The potential effect of blood pressure reduction on cardiovascular disease. A cautionary note.

  1981cited by this paper

• Social determinants of health and cognitive function: A cross‐sectional study among men without dementia

  2023cites this paper
• Low Subjective Cardiovascular Disease Risk Perceptions among Hypertensive Patients in Addis Ababa, Ethiopia

  2022cites this paper
• A Role of Socioeconomic Status in Cognitive Impairment Among Older Adults in Macau: A Decomposition Approach

  2022cites this paper
• CARDIOVASCULAR RISK PROFILE AND RISK STRATIFICATION OF THE HYPERTENSIVE POPULATION: A CROSS-SECTIONAL ANALYSIS OF A 200 PATIENT DATABASE

  2020cites this paper
• Prevalence of hypertension among office workers in a multi-national company in the Niger-Delta with the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines

  2019cites this paper
• Cardiology

  2018cites this paper
• Gender difference in the association between brachial-ankle pulse wave velocity and cardiovascular risk scores

  2018cites this paper
• Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study

  2018cites this paper
• Effectiveness of web-based personalised e‑Coaching lifestyle interventions

  2018cites this paper
• Efficacy and Safety of Nebulized Glycopyrrolate/eFlow® Closed System in Patients with Moderate-to-Very-Severe Chronic Obstructive Pulmonary Disease with Pre-Existing Cardiovascular Risk Factors.

  2018cites this paper
• The impact of unemployment on heart rate variability: the evidence from the Czech Republic.

  2012cites this paper
• Risk Prediction in Cardiovascular Medicine Integrating Information From Novel Risk Factors With Calculated Risks The Critical Impact of Risk Factor Prevalence

  2011cites this paper
• Gap between evidence and physicians' knowledge and practice regarding hypertension and its drug treatment: a survey in a Chinese city.

  2011cites this paper
• Integrating information from novel risk factors with calculated risks: the critical impact of risk factor prevalence.

  2011cites this paper
• The Effect of How Outcomes Are Framed on Decisions about Whether to Take Antihypertensive Medication: A Randomized Trial

  2010cites this paper
• How willing are the public to pay for anti-hypertensive drugs for primary prevention of cardiovascular disease: a survey in a Chinese city.

  2010cites this paper
• To compare the efficacy of blood pressure reduction with or without the biochemical profile

  2010cites this paper
• Health beliefs and cardiovascular risk factors in postmenopausal women in Iran.

  2009cites this paper
• Hipertensión arterial sistémica: de la adaptación a los riesgos

  2005cites this paper
• Chapter 21 – The Concept of Total Risk

  2005cites this paper
• May subclinical arterial disease help to better detect and treat high-risk asymptomatic individuals?

  2005cites this paper
• A diagnosis of left ventricular hypertrophy on ECG is associated with a high cardiovascular risk: findings from a 40- to 69-year-old cohort in general practice.

  2004cites this paper
• A diagnosis of left ventricular hypertrophy on ECG is associated with a high cardiovascular risk : findings from a 40-to 69-year-old cohort in general practice

  2004cites this paper
• Renal immunology and pathology Renal fibrosis Related review: Novel insights into renal fibrosis

  2003cites this paper
• Intermittent fasting and dietary supplementation with 2‐deoxy‐D‐glucose improve functional and metabolic cardiovascular risk factors in rats

  2003cites this paper
• A practical approach to hypertension in the 21st century.

  2003cites this paper
• Coronary and cardiovascular risk estimation in uncomplicated mild hypertension. A comparison of risk assessment methods

  2002cites this paper